Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Microbot Medical Inc.NASDAQ: MBOT
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 156.0% from a year ago
Total equity stood at $74.11M at the end of Q1 FY2026, up 156.0% from a year earlier and down 4.4% from the prior quarter. Over 3 fiscal years it compounded at +119.9% a year.
Context
- Total equity amounted to 94.9% of total assets at the end of Q1 FY2026, up 1.2 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +156.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 77.55M USD
- Year-over-year change
- +2097.0%
- 4-year CAGR
- +52.4%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 77.55M | +2097.0% |
| FY2024 | 2024-12-31 | 3.53M | -21.6% |
| FY2023 | 2023-12-31 | 4.5M | -38.2% |
| FY2022 | 2022-12-31 | 7.29M | -49.3% |
| FY2021 | 2021-12-31 | 14.38M | — |
Total Equity vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +156.0% is the 2nd highest of 10, against a peer median of -33.4%.
- Total equity amounts to 94.9% of total assets for MBOT, versus a peer median of 77.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $238.28M USD | +70.3% | +9.7% | 88.6% | |
| Mar 2026 | $198.27M USD | +234.5% | -0.4% | 87.9% | |
| Mar 2026 | $111.21M USD | -63.2% | -23.3% | 53.2% | |
| Mar 2026 | $74.11M USD | +156.0% | +119.9% | 94.9% | |
| Mar 2026 | $52.2M USD | -42.6% | +20.3% | 88.7% | |
| Mar 2026 | CA$24.27M CAD | +38.0% | -22.6% | 77.1% | |
| Mar 2026 | $19.09M USD | +64.2% | -29.2% | 45.1% | |
| Mar 2026 | CA$9.83M CAD | -33.4% | -31.4% | 65.0% | |
| Mar 2026 | -$18.81M USD | -278.2% | — | 86.8% | |
| Mar 2026 | -$23.17M USD | -406.8% | — | 44.9% | |
| Peer median (excluding MBOT) | — | -33.4% | -22.6% | 77.1% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.